ROCKVILLE, MD, Feb. 26, 2021 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences in March:

Read this article:
MacroGenics to Participate in Upcoming Investor Conferences

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh